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TTsuyoshi Kaneko, MD, Maroun Yammine, MD, and Sary F. Aranki, MD, Boston, MassEditorial Commentary 1802 Novel oral anticoagulation agents: New drugs create new paradigms
Jerrold H. Levy, MD, FAHA, FCCM, Durham, NCET
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1804 Individual differences in field independence influence the ability to
determine accurate needle anglesSAhmad Y. Sheikh, MD, Madeleine Keehner, PhD, Audrey Walker, BS, Paul A. Chang, BS,
Thomas A. Burdon, MD, and James I. Fann, MD, Stanford and Palo Alto, Calif; and Dundee,
United KingdomWe investigated whether the cognitive trait of field dependence correlated with the execution of
surgical tasks in a simulated environment. Our findings suggest that individuals described as
‘‘field independent’’ might be more adept at predicting appropriate needle angle loads.
MEditorial Commentary 1811 Should we perform extensive psychologic testing of our surgical trainees?PPaul Sergeant, MD, PhD, Leuven, Belgium)
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116A The Journal of Thoracic an812 Graft patency after off-pump coronary artery bypass surgery is inferior even
with identical heparinization protocols: Results from the Danish On-pump
Versus Off-pump Randomization Study (DOORS)(continued on page 17A
d Cardiovascular Surgery c November 2014Kim Houlind, MD, PhD, Morten Fenger-Grøn, MSc, Susanne J. Holme, MD,
Bo J. Kjeldsen, MD, PhD, Susanne N. Madsen, MD, Bodil S. Rasmussen, MD, PhD,
Mogens H. Jepsen, MD, Jan Ravkilde, MD, DMSc, Jens Aaroe, MD, DMSc,
Peter Riis Hansen, MD, DMSc, Henrik Steen Hansen, MD, DMSc, and
Poul Erik Mortensen, MD, for the DOORS Study Group, Aarhus, Odense,
Gentofte, and Aalborg, DenmarkNine hundred patients were randomized to on-pump or off-pump coronary artery bypass surgery.
Identical heparinization protocols were applied to both groups. After 6 months, 481 patients
underwent coronary angiography. Among off-pump patients, 21% of grafts were stenotic or
occluded compared with 14% in the on-pump group (P 5 .01).1820 Worse long-term survival after off-pump than on-pump coronary artery
bypass grafting
Hisato Takagi, MD, PhD, and Takuya Umemoto, MD, PhD, for the All-Literature Investigation of
Cardiovascular Evidence (ALICE) Group, Shizuoka, JapanAmeta-analysis of 5 randomized controlled trials and 17 adjusted observational studies enrolling a
total of 104,306 patients demonstrated a statistically significant 7% increase in long-term ($5
years) all-cause mortality with off-pump relative to on-pump CABG (HR, 1.07; 95% CI, 1.03-1.11;
P 5 .0003).Editorial Commentary 1829 Should off-pump coronary artery bypass surgery be abandoned?
A potential solution
Harold L. Lazar, MD, Boston, Mass1832 Analysis of the learning curve for beating heart, totally endoscopic, coronary
artery bypass grafting
Nan Cheng, MD, Changqing Gao, MD, Ming Yang, MD, Yang Wu, MD, Gang Wang, MD, and
Cangsong Xiao, MD, Beijing, ChinaTECAB can be performed safely in a stepwise approach. Each modular has a substantial learning
curve; however, the operative results were excellent after the learning curve.1837 Meta-analysis of minimally invasive coronary artery bypass versus
drug-eluting stents for isolated left anterior descending coronary artery
disease
Ralf E. Harskamp, MD, Judson B. Williams, MD, MHS, Michael E. Halkos, MD, MSc,
Renato D. Lopes, MD, PhD, MHS, Jan G. P. Tijssen, PhD, T. Bruce Ferguson, Jr, MD, and
Robbert J. de Winter, MD, PhD, Durham, NC, Amsterdam, The Netherlands, Atlanta, Ga, and
Greenville, NCIn the present meta-analysis, we found 4 studies (n 5 941) that had compared the outcomes
between MINI-CAB and DES implantation for isolated LAD disease. TVR was lower after MINI-
CAB than after DES implantation (OR, 0.16; 95% CI, 0.08-0.30; P , .0001; number needed to
treat, 13). Otherwise, the incidence of cardiac death, MI, and periprocedural stroke was similar.)
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in patients undergoing off-pump coronary artery bypass grafting:
A propensity-matched comparison(continued on page 18A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 5 17AU
EDToshihiro Fukui, MD, Sachiko Tanaka, MPH, and Shuichiro Takanashi, MD, Tokyo and Kyoto,
JapanWe aimed to compare early and long-term outcomes of patients with and without previous coronary
stents undergoing off-pump coronary artery bypass grafting. After propensity matching based on
preoperative risk factors, early and long-term outcomes were comparable between the groups.1CD850 AusSCORE II in predicting 30-day mortality after isolated coronary artery
bypass grafting in Australia and New ZealandABaki Billah, PhD, Molla M. Huq, MSc, Julian A. Smith, MBBS, Fahim Sufi, PhD,
Lavinia Tran, PhD, Gilbert C. Shardey, MBBS, and Christopher M. Reid, PhD, Melbourne,
Clayton, and Malvern, Victoria, AustraliaUsing bootstrapping methods, a 30-day mortality risk prediction algorithm was derived to calculate
a patient’s absolute risk. This algorithm will be useful to assess the preoperative risk of mortality
and to improve preoperative risk consultation. D1856 Chronic competitive flow from a patent arterial or venous graft to the
circumflex system does not impair the long-term patency of internal thoracic
artery to left anterior descending grafts in patients with isolated predivisional
left main disease: Long-term angiographic results of 2 different
revascularization strategiesCH
TSMario Gaudino, MD, Massimo Massetti, MD, Piero Farina, MD, Claude Hanet, MD,
Pierre-Yves Etienne, MD, Andrea Mazza, MD, and David Glineur, MD, Rome, Italy; and
Mont Godinne and Namur, Belgium GWe compared patients with isolated predivisonal left main stenosis treated with double internal
thoracic artery grafts or with internal thoracic artery graft plus saphenous vein bypass. In the long
term, both strategies achieved similar clinical and angiographic results, minimizing the adverse
effect of flow competition in this setting.1ET860 Increased late mortality after coronary artery bypass surgery complicated by
isolated new-onset atrial fibrillation: A comprehensive propensity-matched
analysis/B
SLaila Al-Shaar, MS, MPH, Thomas A. Schwann, MD, Ameer Kabour, MD, and
Robert H. Habib, PhD, Beirut, Lebanon, and Toledo, OhioM
The present study investigated the long-term outcomes of new-onset POAF after CABG. Using
multiple propensity matching methods, we found that POAF increased the long-term mortality
during an 18-year postoperative follow-up period.P1869 Long-term outcomes of coronary artery bypass grafting patients supported
preoperatively with an intra-aortic balloon pump
Eli Hemo, MD, Benjamin Medalion, MD, Rephael Mohr, MD, Yossi Paz, MD,
Amir Kramer, MD, PhD, Gideon Uretzky, MD, Nachum Nesher, MD, and Dmitri Pevni, MD,
Tel Aviv, and Petach Tiqva, IsraelTXIn the present study, we have provided the long-term results of 215 coronary patients supported
preoperatively with IABP. We found that in this subgroup of patients, better early and long-term
results were related to younger age, a shorter CPB time, and a greater number of bypass grafts.)
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TX118A The Journal of Thoracic an876 Continuative statin therapy after percutaneous coronary intervention
improves outcome in coronary bypass surgery: A propensity score
analysis of 2501 patients(continued on page 19A
d Cardiovascular Surgery c November 2014Vito Mannacio, MD, Pascal Meier, MD, Anita Antignano, MD, Michele Mottola, MD,
Luigi Di Tommaso, MD, Francesco Musumeci, MD, and Carlo Vosa, MD, Naples and Rome, Italy;
New Haven, Conn; and London, United KingdomPercutaneous coronary intervention increases the risk of death and complications of coronary artery
bypass grafting. This study evaluated the efficacy of long-term statin treatment on early and
midterm outcomes when surgical revascularization is required.Editorial Commentary 1884 Failure to initiate statin therapy during and after percutaneous coronary
interventions negatively affects coronary artery bypass graft outcomes
Harold L. Lazar, MD, Boston, Mass1887 Toward zero: Deep sternal wound infection after 1001 consecutive coronary
artery bypass procedures using arterial grafts: Implications for diabetic
patients
Teresa M. Kieser, MD, M. Sarah Rose, PhD, Uthman Aluthman, MD, Marlene Montgomery, RN,
Thomas Louie, MD, and Israel Belenkie, MD, Calgary, Alberta, CanadaMultiple infection prevention measures in 1001 CABG procedures (with 98% arterial grafts, 74%
bilateral internal thoracic artery grafting, and 34% diabetic patients), sequentially introduced over
5 years, reduced the deep sternal wound infection rate from 16 of 532 (3%) to 0 of 469 (0%)
(P , .001) for the last 4.5 years.Editorial Commentary 1896 Arterial grafting and the risk of sternal infection: How we can learn from our
experience
Paul Kurlansky, MD, New York, NY1899 Repeat sternotomy for surgical aortic valve replacement in octogenarian
patients with aortic valve stenosis and previous coronary artery bypass
graft operation: What is the operative risk?
Sebastian A. Iturra, MD, Kevin L. Greason, MD, Rakesh M. Suri, MD, Lyle D. Joyce, MD,
John M. Stulak, MD, Alberto Pochettino, MD, and Hartzell V. Schaff, MD, Rochester, MinnRepeat sternotomy for surgical aortic valve replacement can be done safely in octogenarian patients
with severe aortic valve stenosis and previous coronary artery bypass graft surgery. The risk of
operation is no greater than for primary sternotomy. There is no compelling reason to dismiss
operation in appropriate candidates.1903 Long-term results of Freestyle stentless bioprosthesis in the aortic position:
A single-center prospective cohort of 500 patients
Nicolas Amabile, MD, PhD, Olivier M. Bical, MD, Alexandre Azmoun, MD,
Ramzi Ramadan,MD, RemiNottin,MD, andPhilippeH.Deleuze,MD, Le Plessis-Robinson, FranceBetween April 1997 and November 2004, 500 patients underwent AVR with a Freestyle
bioprosthesis. The actuarial survivals from cardiovascular and valve-related mortality were
67% 6 3% and 70% 6 4%, respectively, and freedom from structural valve deterioration was
94% 6 2% at 10 years. The Freestyle bioprosthesis is a valuable option for AVR in all-comers.)
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The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 5 19AJohn Pepper, MD, London, United Kingdom1ED913 Valve repair improves the outcome of surgery for chronic severe aortic
regurgitation: A propensity score analysisUChristophe de Meester, MS, Agnes Pasquet, MD, PhD, Bernhard L. Gerber, MD, PhD,
David Vancraeynest, MD, PhD, Philippe Noirhomme, MD, Gebrine El Khoury, MD, and
Jean-Louis J. Vanoverschelde, MD, PhD, Brussels, BelgiumA
CDAortic valve repair and aortic valve replacement were compared in the treatment of severe aortic
regurgitation. A propensity score analysis was built using 44 pairs of patients. Survival analysis
indicated a significantly better overall 9-year survival after aortic valve repair than after aortic valve
replacement (87% vs 60%; log rank P 5 .007).1921 Capturing echocardiographic allograft valve function over time after allograft
aortic valve or root replacementH
DM. Mostafa Mokhles, PhD, MSc, Jeevanantham Rajeswaran, MSc, Jos A. Bekkers, MD,
Gerard J. J. M. Borsboom, MSc, Jolien W. Roos-Hesselink, MD, PhD, Ewout W. Steyerberg, PhD,
Ad J. J. C. Bogers,MD, PhD, Johanna J.M. Takkenberg,MD, PhD, and Eugene H. Blackstone, MD,
Rotterdam, The Netherlands, and Cleveland, OhioCBoth aortic regurgitation and stenosis increase over time after allograft aortic valve or root
replacement and are the most important cause of allograft failure. The analysis of allograft valve
function is complex and requires advanced longitudinal models for adequate statistical analysis.Editorial Commentary 1929 The importance of longitudinal assessment of valve functionSThierry Carrel, MD, Berne, Switzerland T1931 Late outcomes comparison of nonelderly patients with stented bioprosthetic
and mechanical valves in the aortic position: A propensity-matched analysisG
SR. Scott McClure, MD, SM, Siobhan McGurk, BA, Marisa Cevasco, MD, Ann Maloney, BA,
Igor Gosev, MD, Esther M. Wiegerinck, MD, Genina Salvio, PA, George Tokmaji, MD,
Wernard Borstlap, AB, Foeke Nauta, AB, and Lawrence H. Cohn, MD, Boston, Mass, and Kingston,
Ontario, CanadaET
/BThere are conflicting results in the contemporary surgical literature regarding the effect of valve
choice on late mortality in nonelderly patients. This propensity-matched analysis of 361
patient-pairs aged ,65 years shows no difference in late mortality for mechanical and stented
bioprosthetic valves in the aortic position out to 18 years.1940 Comparison of early hemodynamic performance of 3 aortic valve
bioprosthesesMP
Murat Ugur, MD, Rakesh M. Suri, MD, DPhil, Richard C. Daly, MD, Joseph A. Dearani, MD,
Soon J. Park, MD, Lyle D. Joyce, MD, PhD, Harold M. Burkhart, MD, Kevin L. Greason, MD, and
Hartzell V. Schaff, MD, Rochester, MinnWe compared the early postoperative hemodynamic results of the Trifecta (St Jude Medical,
St Paul, Minn), Mitroflow (Sorin Group, Milan, Italy), and Perimount Magna (Edwards
Lifesciences Corp, Irvine, Calif) aortic valve bioprostheses. The Trifecta prosthesis had a lower
mean gradient and a slightly greater valve area.)
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TX120A The Journal of Thoracic an947 Papillary muscle relocation and mitral annuloplasty in ischemic mitral valve
regurgitation: Midterm results(continued on page 21A
d Cardiovascular Surgery c November 2014Khalil Fattouch, MD, PhD, Sebastiano Castrovinci, MD, Giacomo Murana, MD,
Pietro Dioguardi, MD, Francesco Guccione, MD, Giuseppe Nasso, MD, and
Giuseppe Speziale, MD, Palermo, Bologna, and Bari, ItalyThere are many opinions in favor of adding papillary muscle relocation to mitral valve annuloplasty
to reduce tenting forces and improve repair results. In our experience, this approach is an easy and
safe method, with a reverse in left ventricle remodeling and low cardiac related-events and deaths at
midterm follow-up.1951 Five-year real world outcomes of GeoForm ring implantation in patients with
ischemic mitral regurgitation
Tomasz A. Timek, MD, Robert L. Hooker, MD, Robin Collingwood, MD, Alan T. Davis, PhD,
Craig T. Alguire, MD, Charles L. Willekes, MD, Edward T. Murphy, MD, John C. Heiser, MD, and
Lawrence H. Patzelt, MD, Grand Rapids, MichStandard undersized ring annuloplasty repair of IMR has yielded suboptimal results and
etiology-specific prostheses such as the GeoForm ring have been developed to improve clinical
outcomes. In our series of 86 patients with IMR, GeoForm ring implantation was associated with
very good control of IMR, a low rate of recurrent IMR, and satisfactory 5-year survival.1957 Influence of mitral valve repair versus replacement on the development of late
functional tricuspid regurgitation
Bijoy G. Rajbanshi, MBBS, Rakesh M. Suri, MD, DPhil, Vuyisile T. Nkomo, MD, MPH,
Joseph A. Dearani, MD, Richard C. Daly, MD, Harold M. Burkhart, MD, John M. Stulak, MD,
Lyle D. Joyce, MD, PhD, Zhuo Li, MS, and Hartzell V. Schaff, MD, Rochester, MinnControversy has persisted regarding the determinants of late functional TR after surgical correction
of MR due to degenerative MV disease. We evaluated the determinants of functional TR
progression, including the influence of MVr versus MVR for degenerative MR.Editorial Commentary 1962 ‘‘Forgotten’’ valve or ‘‘enigmatic’’ valve? Further insights into the tricuspid
valve in patients undergoing mitral valve surgery
Elizabeth H. Stephens, MD, PhD, and Michael A. Borger, MD, PhD, New York, NY1965 Hybrid approach for transcatheter paravalvular leak closure of mitral
prosthesis in high-risk patients through transapical access
Giedrius Davidavicius, MD, Kestutis Rucinskas, MD, Agne Drasutiene, MD,
Robertas Samalavicius, MD, Valdas Bilkis, MD, Diana Zakarkaite, MD, and Audrius Aidietis, MD,
Vilnius, LithuaniaWe report the success of mitral PVL closure through the apex. Mitral PVL closure with the AVP III
device was successfully performed in 6 of 7 patients. Mitral PVL closure reduced the regurgitation
grade and improved symptoms.)
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atrial fibrillation and mitral stenosis(continued on page 22A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 5 21AUZhi-Qiang Luo, MD, Xing-Hai Hao, MD, Jin-Hua Li, MD, Jiang Dai, MD, Ke-Ye Liu, MD, and
Yong-Qiang Lai, MD, Baoding, Hebei, and Beijing, ChinaEDLeft atrial endocardial dysfunction and platelet activation were seen in patients with atrial
fibrillation and mitral stenosis. In collaboration, von Willebrand factor and P-selectin may play a
role in left atrial thrombosis in response to endothelial injury to the left atrial appendage.Editorial Commentary 1976 Atrial thrombosis in advanced mitral stenosis with atrial fibrillation: What
should we expect?CDCarlos-A. Mestres, MD, PhD, FETCS, Abu Dhabi, United Arab EmiratesA1978 Timing of valve repair for severe degenerative mitral regurgitation and
long-term left ventricular function
Takeshi Kitai, MD, Yukikatsu Okada, MD, Yu Shomura, MD, Tomoko Tani, MD,
Shuichiro Kaji, MD, Toru Kita, MD, and Yutaka Furukawa, MD, Kobe, JapanD
CHA total of 473 patients who underwent MV repair were reviewed to evaluate postoperative LV
dysfunction. MV repair with LV ejection fraction .63% and LVESD ,39 mm preserved 3-year
postoperative LV function well, and smaller LVESD was associated with long-term LV function
recovery.1983 Impact of tricuspid regurgitation after redo valvular surgery on survival in
patients with previous mitral valve replacementG
TSNaoto Fukunaga, MD, Yukikatsu Okada, MD, PhD, Yasunobu Konishi, MD,
Takashi Murashita, MD, Hideo Kanemitsu, MD, PhD, and Tadaaki Koyama, MD, PhD, Kobe,
JapanSurvival in patients with tricuspid regurgitation greater than mild after redo valvular surgery was
poor. It is important to maintain postoperative tricuspid regurgitation less than moderate to improve
long-term survival.1B989 Mitral valve surgery: Right lateral minithoracotomy or sternotomy?
A systematic review and meta-analysisS
T/ESimon H. S€undermann, MD, Juri Sromicki, MD, Hector Rodriguez Cetina Biefer, MD,
Burkhardt Seifert, MD, PhD, Tomas Holubec, MD, Volkmar Falk, MD, PhD, and
Stephan Jacobs, MD, Zurich, Switzerland, and Boston, MassM
The current evidence on right lateral minithoracotomy versus conventional mitral valve surgery
was updated by performing a contemporary literature review and meta-analysis. Forty-five studies
involving more than 20,000 patients were included. The results show a similar perioperative
outcome for both techniques.)
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TX122A The Journal of Thoracic an996 Short- and long-term outcomes after valve replacement surgery for rheumatic
heart disease in the South Pacific, conducted by a fly-in/fly-out humanitarian
surgical team: A 20-year retrospective study for the years 1991 to 2011(continued on page 23A
d Cardiovascular Surgery c November 2014Linda Thomson Mangnall, MN (Hons), David Sibbritt, PhD, Margaret Fry, PhD, and
Robyn Gallagher, PhD, Wahroonga and Sydney, AustraliaFiji has used humanitarian fly-in/fly-out teams to provide valve replacement for rheumatic heart
disease surgery since 1991. This research investigated mortality, morbidity, and major adverse
valve-related events from 1991 to 2011. Although many people do well, this research identified
some concerns, particularly with outcomes for female patients. Evidence suggests that these
outcomes would benefit from systematic long-term surveillance.2004 Very late outcomes for mitral valve replacement with the Carpentier-Edwards
pericardial bioprosthesis: 25-year follow-up of 450 implantations
Thierry Bourguignon, MD, Anne-Lorraine Bouquiaux-Stablo, MD, Claudia Loardi, MD,
Alain Mirza, MD, Pascal Candolfi, PhD, Michel Marchand, MD, andMichel R. Aupart, MD, Tours,
France, and Nyon, SwitzerlandFrom 1984 to 2011, 450 Carpentier-Edwards PERIMOUNT pericardial mitral bioprostheses were
implanted in 404 consecutive patients. With a low rate of valve-related events at 20 years, the
Carpentier-Edwards PERIMOUNT pericardial bioprosthesis remains a reliable choice for a mitral
tissue valve, especially in patients .60 years old.2012 Effects of right ventricular morphology and function on outcomes of patients
with degenerative mitral valve disease
Ying Ye, BS, Ravi Desai, MD, Lina M. Vargas Abello, MD, Jeevanantham Rajeswaran, PhD,
Allan L. Klein, MD, Eugene H. Blackstone, MD, and G€osta B. Pettersson, MD, PhD, Cleveland,
OhioTogether with patient comorbidities and operative factors, right ventricular morphology and
function are stronger determinants of preoperative organ dysfunction and prognosis than the degree
of functional tricuspid regurgitation in patients undergoing surgery for degenerative mitral valve
disease.2021 Relationship among surgical volume, repair quality, and perioperative
outcomes for repair of mitral insufficiency in a mitral valve reference center
Menachem M. Weiner, MD, Ira Hofer, MD, Hung-Mo Lin, DSc, Javier G. Castillo, MD,
David H. Adams, MD, and Gregory W. Fischer, MD, New York, NY, and Los Angeles, CalifAs the number of mitral valve repairs performed by a single surgeon at a single institution
increased, a significant reduction occurred in the aortic crossclamp times, despite an increase in the
complexity of the procedures. This led to a reduction in perioperative morbidity.2027 Very long-term durability of the edge-to-edge repair for isolated anterior
mitral leaflet prolapse: Up to 21 years of clinical and echocardiographic results
Michele De Bonis, MD, Elisabetta Lapenna, MD, Maurizio Taramasso, MD,
Giovanni La Canna, MD, Nicola Buzzatti, MD, Federico Pappalardo, MD, and Ottavio Alfieri, MD,
Milan, ItalyThe aim of the present study was to assess the very long-term clinical and echocardiographic results
of EE repair for MR due to isolated prolapse or flail of the anterior leaflet. The freedom from MR
grade$31 at 17 years was 80.2%6 5.86%. In patients with MR due to segmental anterior leaflet
prolapse, the very long-term results of EE repair combined with annuloplasty were excellent.)
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technique in mitral valve repair: A single-center experience of 700 cases(continued on page 24A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 5 23AUMinoru Tabata, MD, MPH, Hitoshi Kasegawa, MD, Toshihiro Fukui, MD, Atsushi Shimizu, MD,
Yasunori Sato, PhD, and Shuichiro Takanashi, MD, Tokyo and Chiba, JapanEDThe tourniquet technique is a simple and effective method to determine the length of artificial
chordae in mitral valve repair, with a low incidence of recurrent prolapse.2039 Single center experience with the Sorin Bicarbon prosthesis: A 17-year clinical
follow-upCDMichele Celiento, MD, Luca Filaferro, MD, Aldo D. Milano, MD, PhD, FECTS,
Gerardo Anastasio, MD, Gabriele Ferrari, MD, and Uberto Bortolotti, MD, FACC, FECTS, Pisa
and Verona, Italy AReview of a series of 507 patients with a Sorin Bicarbon mechanical prosthesis at a maximum
follow-up of 17 years showed excellent results in terms of clinical improvement and freedom from
valve-related complications, indicating that this device is a safe and valid option whenever a
mechanical prosthesis is required.2CH045 Minimally invasive fibrillating mitral valve replacement for patients with
advanced cardiomyopathy: A safe and effective approach to treat a complex
problemDEvan L. Brittain, MD, Sandeep K. Goyal, MD, Matthew A. Sample, MD, Marzia Leacche, MD,
Tarek S. Absi, MD, Frank Papa, PhD, Keith B. Churchwell, MD, Stephen Ball, MD,
John G. Byrne, MD, Simon Maltais, MD, PhD, Michael R. Petracek, MD, and Lisa Mendes, MD,
Nashville, TennG
TSThe optimal management of MR in patients with cardiomyopathy has been controversial. We have
described a minimally invasive fibrillating technique to address severe MR. MVR with complete
chordal sparing was found to be safe and effective, with favorable mortality compared with the
Society of Thoracic Surgeons-predicted mortality.2052 Outcome after surgery for prosthetic valve endocarditis and the impact of
preoperative treatmentT/
B
SHerko Grubitzsch, MD, PhD, Andreas Schaefer, Christoph Melzer, MD, PhD,
Klaus-Dieter Wernecke, MD, PhD, Davide Gabbieri, MD, and Wolfgang Konertz, MD, PhD,
Berlin, Germany, and Modena, ItaliaEThis study examined the outcomes of surgery for active prosthetic valve endocarditis in the recent
decade: Cardiac and renal function, need for double valve replacement, and preoperative treatment
predicted outcomes. A prolonged interval in which patients were left untreated while symptomatic,
but not prolongation of preoperative antibiotic treatment, increased risk.2
P060 Effect of aortic aneurysm replacement on outcomes after bicuspid aortic valve
surgery: Validation of contemporary guidelinesMDaniel Rinewalt, MD, Patrick M. McCarthy, MD, Sukit Chris Malaisrie, MD,
Paul W. M. Fedak, MD, PhD, Adin-Cristian Andrei, PhD, Jyothy J. Puthumana, MD, and
Robert O. Bonow, MD, Chicago, Ill, and Calgary, Alberta, CanadaTXBAV disease is associated with a known aortopathy. We reviewed 456 operations in patients with
BAVand compared the morbidity and mortality by AD size. In the patients with BAV undergoing
aortic valve replacement, no increase was seen in morbidity and mortality when adding aneurysm
replacement in those with an AD of 45 to 49 mm.)
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TXEditorial Commentary 224A The Journal of Thoracic an070 Sound arguments, true premises, and valid conclusions(continued on page 25A
d Cardiovascular Surgery c November 2014Thoralf M. Sundt, MD, Boston, Mass2072 Toward individualized management of the ascending aorta in bicuspid aortic
valve surgery: The role of valve phenotype in 1362 patients
Hans-Hinrich Sievers, MD, Ulrich Stierle, MD, Salah A. Mohamed, PhD, MD,
Thorsten Hanke, MD, Doreen Richardt, MD, Claudia Schmidtke, MD, and
Efstratios I. Charitos, MD, L€ubeck, GermanyIndividualized multifactorial decision making for the management of the AA during BAV surgery
leads to excellent results. BAV type 2/unicuspid and BAV type 1 with regurgitation emerged as
determinants for decision making.Editorial Commentary 2080 Bicuspid aortopathy and the development of individualized resection strategies
Paul W. M. Fedak, MD, PhD, FRCSC, and Subodh Verma, MD, PhD, FRCSC, Chicago, Ill, and
Calgary and Toronto, Alberta, Canada2082 Insurance status predicts acuity of thoracic aortic operations
Nicholas D. Andersen, MD, Jennifer M. Hanna, MD, MBA, Asvin M. Ganapathi, MD,
Syamal D. Bhattacharya, MD, Judson B. Williams, MD, MHS, Jeffrey G. Gaca, MD,
Richard L. McCann, MD, and G. Chad Hughes, MD, Durham, NCThis study explored the association between insurance status and the need for nonelective thoracic
aortic surgery in a retrospective single-institution series (n 5 826). Results showed that
underinsured patients were at the greatest risk of requiring nonelective thoracic aortic operation,
possibly because of decreased use of lipid-lowering therapies and aortic surveillance.2087 Longevity after mechanical aortic root replacement—do men live longer?
Felix Girrbach, MD, Christian D. Etz, MD, PhD, Pascal M. Dohmen, MD, PhD,
Konstantin von Aspern, MD, Maximilian Luehr, MD, Michael A. Borger, MD, PhD,
Martin Misfeld, MD, PhD, Sandra Eifert, MD, PhD, and Friedrich-Wilhelm Mohr, MD, PhD,
Leipzig, GermanyA total of 476 patients (376 men) underwent composite aortic root replacement at our institution
from February 1998 through June 2011. Overall, long-term survival after mechanical aortic root
replacement was significantly better among men. However, comparing age-matched subgroups
#55 years of age, no significantly difference was found in life expectancy.2096 In situ total aortic arch replacement for infected distal aortic arch aneurysms
with penetrating atherosclerotic ulcer
Kenji Okada, MD, PhD, Katsuhiro Yamanaka, MD, Toshihito Sakamoto, MD, Takeshi Inoue, MD,
Masamichi Matsumori, MD, PhD, Fumi Kawakami, MD, and Yutaka Okita, MD, PhD, Kobe, JapanNine patients with infected distal aortic arch saccular aneurysms with penetrating atherosclerotic
ulcer underwent total aortic arch replacement. Radical debridement with in situ total aortic arch
replacement was performed in all patients, followed by omental flap grafting in 7 patients. There
was no in-hospital mortality or recurrence of infection.)
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L2101 Surgical repair of descending thoracic and thoracoabdominal aortic aneurysm
involving the distal arch: Open proximal anastomosis under deep hypothermia
versus arch clamping technique(continued on page 26A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 5 25AU
EDJae Suk Yoo, MD, Joon Bum Kim, MD, PhD, Sung-Ho Jung, MD, PhD, Suk Jung Choo, MD, PhD,
Cheol Hyun Chung, MD, PhD, and Jae Won Lee, MD, PhD, Seoul, South KoreaIn this analysis of 174 patients undergoing descending thoracic or thoracoabdominal aortic repair
using DHCA (n5 81) versus the AC technique (n5 93), both groups showed similar postoperative
mortality and morbidity, except for a need for prolonged ventilator support with DHCA.2108 Combined endovascular and surgical approach for aortobronchial fistulaCD
ALudovic Canaud, MD, PhD, Thomas D’Annoville, MD, Baris Ata Ozdemir, FRCS,
Charles Marty-Ane, MD, PhD, and Pierre Alric, MD, PhD, Montpellier, FranceCH
DEmergency TEVAR for aortobronchial fistula is an appealing strategy for this devastating
complication. However, to achieve a lasting result, direct contact between the stent graft and the
pulmonary tissue should be avoided to prevent further erosive damage. Concomitant or staged
repair should entail primary repair or resection and anastomosis of the bronchus and/or pulmonary
resection with coverage of the stent graft using muscle or pleural flaps combined with broad-
spectrum intravenous antibiotic therapy. Long-term surveillance and continued investigation are
warranted.2112 Endovascular treatment of late coronary-subclavian steal syndrome
Gianluca Faggioli, MD, Rodolfo Pini, MD, Alberto Cremonesi, MD, Chiara Grattoni, MD,
Matteo Longhi, MD, Raffaella Mauro, MD, Fausto Castriota, MD, and Andrea Stella, MD,
Bologna, and Cotignola, Ravenna, ItalyG
TSCSSS is a rare cause of myocardial ischemia subsequent to stenosis or occlusion of the SA proximal
to an ITA coronary bypass. Only single cases have been reported in published studies. We report 10
patients treated through an endovascular approach.2117 Long-term outcomes of survival and freedom from reoperation on the aortic
root or valve after surgery for acute ascending aorta dissectionS
ET
/BZhengjun Wang, MD, Kevin L. Greason, MD, Alberto Pochettino, MD, Hartzell V. Schaff, MD,
RakeshM. Suri, MD, JohnM. Stulak, MD, and Joseph A. Dearani, MD, Rochester, Minn, and Jinan,
ChinaThe operative morbidity and mortality rates were significant after repair of acute ascending aorta
dissection. Aggressive aortic root surgery resulted in operative mortality, long-term survival, and
freedom from reoperation on the aortic root or valve similar to those after isolated ascending aorta
replacement.Editorial Commentary 2123 Acute ascending aortic dissection: Support for limited distal repair PMJoseph S. Coselli, MD, Houston, Tex)
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TX226A The Journal of Thoracic an125 Early and midterm outcomes of hemiarch replacement combined with stented
elephant trunk in the management of acute DeBakey type I aortic dissection:
Comparison with total arch replacement(continued on page 27A
d Cardiovascular Surgery c November 2014Enyi Shi, MD, PhD, Tianxiang Gu, MD, PhD, Yang Yu, MD, Lei Yu, MD, Chun Wang, MD, PhD,
Qin Fang, MD, and Yuhai Zhang, MD, PhD, Shenyang, ChinaFor patients with acute DeBakey type I dissection without an intimal tear in the arch, hemiarch
replacement with stented elephant trunk implantation was easily performed with satisfactory early
and midterm outcomes. For these selective patients, total arch replacement with stented elephant
trunk implantation did not improve the late surgical results further.2132 Surgery for acute aortic dissection using the Chinese CRONUS stented
elephant trunk technique: Experience with 252 patients
Hong-bing Wu, MD, Hao Zhang, MD, Zhi-wei Wang, PhD, Rui Hu, MD, Luo-cheng Li, MD,
Min Zhang, MD, and Xiao-ping Hu, MD, Wuhan Hubei, People’s Republic of ChinaTo evaluate the effectiveness of surgical treatment for acute aortic dissection using the Chinese
CRONUS stented elephant trunk technique, we reviewed our experience with 252 patients with
acute aortic dissection who underwent surgical treatment using the Chinese CRONUS stented
elephant trunk technique. It showed that the technique is safe and effective for patients with acute
aortic dissection.Editorial Commentary 2138 Another approach to dissection involving the aortic arch
Lars G. Svensson, MD, PhD, Cleveland, Ohio2140 Effect of false lumen partial thrombosis on repaired acute type A aortic
dissection
Meng-Ta Tsai, MD, Hsuan-Yin Wu, MD, Jun-Neng Roan, MD, Yi-Shan Tsai, MD,
Patrick C. H. Hsieh, MD, PhD, Yu-Jen Yang, MD, and Chwan-Yau Luo, MD, MSc, Tainan, TaiwanStudies on the partial thrombosis of false lumens after repairing TAAAD have reported conflicting
results. We reviewed the postoperative CT scans of 67 patients. Partial thrombosis of a
postoperative residual false lumen predicted a greater regional aortic growth and reoperation rate
but did not affect long-term overall survival.2147 Simplified total arch repair with a stented graft for acute DeBakey type I
dissection
Enyi Shi, MD, PhD, Tianxiang Gu, MD, PhD, Yang Yu, MD, Chun Wang, MD, PhD, Lei Yu, MD,
Qin Fang, MD, and Yuhai Zhang, MD, PhD, Shenyang, ChinaWith the use of a self-designed stented graft, of which the proximal 10 cm is free of stent, a
simplified technique was developed for total arch repair with stented elephant trunk implantation
with no need to anastomose the graft to the descending aorta and 3 arch vessels.)
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type B dissection(continued on page 28A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 5 27AED
UJochen Grommes, MD, Andreas Greiner, MD, Bianca Bendermacher, MD, Max Erlmeier, MD,
Andreas Frech, MD, Perrine Belau, MD, Lieven N. Kennes, PhD, Gustav Fraedrich, MD,
Geert Wilhelm Schurink, MD, PhD, Michael J. Jacobs, MD, PhD, and Josef Klocker, MD, Aachen,
Germany; Innsbruck, Austria; and Maastricht and Eindhoven, The NetherlandsUncomplicated cases of type B dissection are treated conservatively. Our results identified early
aortic dilatation and old age as risk factors for increasedmortality during follow-up, and early aortic
dilation displayed a higher rate of treatment failure of conservative treatment, indicating that this
subgroup might benefit from more aggressive therapy.2A161 Event recordermonitoring to compare the efficacy of a left versus biatrial lesion
set in patients undergoing concomitant surgical ablation for atrial fibrillationCDSimon Pecha, MD, Friederike Hartel, MD, Teymour Ahmadzade, MD, Muhammet Ali Aydin, MD,
Stephan Willems, MD, Hermann Reichenspurner, MD, PhD, and Florian Mathias Wagner, MD,
Hamburg, GermanyCH
DIn our study, using continuous ER rhythm monitoring to compare the efficacy of a left versus
biatrial lesion set for surgical AF ablation, subcutaneous ER implantation was safe and feasible.
In patients undergoing biatrial ablation, a statistically significant rate of freedom from AF was
observed at 12 months follow-up.2167 Outcomes of cardiac surgery in chronic kidney disease
Mangalee Fernando, FRACP, Hugh S. Paterson, FRACS, Karen Byth, PhD,
Benjamin M. Robinson, MBBS, MPhil, HughWolfenden, FRACS, David Gracey, PhD, FRACP, and
David Harris, MD, BS, FRACP, Sydney, AustraliaS
G
TWe performed a multicenter study of the cardiac surgery outcomes in 545 patients with renal
failure. The perioperativemortality was 13.9%, and the 10-year survival was 36%. Coronary bypass
surgery and left heart valve replacement patients had similar long-term outcomes. A preoperative
eGFR ,20 mL/min increased the risk of requiring dialysis within 6 months.2174 Analysis of risk factors for recurrence after video-assisted pulmonary vein
isolation of lone atrial fibrillation—results of 5 years of follow-upS
/BQiu-Ming Hu, MD, Yan Li, MD, Chun-Lei Xu, MD, Jie Han, MD, Hai-Bo Zhang, MD,
Wei Han, MD, and Xu Meng, MD, Beijing, People’s Republic of ChinaETWe have reported .5 years of follow-up data of video-assisted minimally invasive surgery for
91 cases of lone AF. At the 5-year follow-up point, 43 of 78 patients (55.1%) were in NSR. Of the
39 patients with PAF and 39 with non-PAF, 27 (69.2%) and 16 (44.1%) were in NSR, respectively.
The preoperative LAD and AF duration were most important predictors of late AF recurrence.PM
Congenital Heart
Disease (CHD)
2181 Time to surgery and preoperative cerebral hemodynamics predict postoperative
white matter injury in neonates with hypoplastic left heart syndrome
Jennifer M. Lynch, PhD, Erin M. Buckley, PhD, Peter J. Schwab, BS, Ann L. McCarthy, BBA,
Madeline E. Winters, BA, David R. Busch, PhD, Rui Xiao, PhD, Donna A. Goff, MD, MS,
Susan C. Nicolson, MD, Lisa M. Montenegro, MD, Stephanie Fuller, MD, J. William Gaynor, MD,
Thomas L. Spray, MD, Arjun G. Yodh, PhD, Maryam Y. Naim, MD, and Daniel J. Licht, MD,
Philadelphia, Pa, Charlestown, Mass, and Loma Linda, CalifTXWeinvestigated the risk factors for new, orworsened, postoperativewhitematter injury in neonateswith
HLHS. We quantified the pre- and postoperative cerebral hemodynamics with noninvasive optical
spectroscopy and found that a longer time to surgery is highly associatedwith this postoperative injury.)
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TXEditorial Commentary 228A The Journal of Thoracic an188 Should we be doing the Norwood procedure sooner?(continued on page 29A
d Cardiovascular Surgery c November 2014Richard A. Jonas, MD, Washington, DC2190 Neurologic and psycho-intellectual outcome related to structural brain
imaging in adolescents and young adults after neonatal arterial switch
operation for transposition of the great arteries
Anna Kathrin M. Heinrichs, Annika Holschen, MD, Timo Krings, MD, Bruno J. Messmer, MD,
Ralph Schnitker, PhD, Ralf Minkenberg, Dipl-Phys, and Hedwig H. H€ovels-G€urich, MD, Aachen
and Ingelheim, GermanyDespite encouraging average neurodevelopmental outcomes, a significant minority will perform
below the expected level, emphasizing the need for ongoing surveillance, therapeutic intervention,
and rehabilitation. A high incidence of structural brain abnormalities on magnetic resonance
imaging suggests additional assessment is necessary to determine its prognostic value for
neuropsychological development.Editorial Commentary 2199 Leaving the nest: Facing adulthood after the arterial switch operation
Frank A. Pigula, MD, Boston, Mass2201 Predictors of 90-day mortality after congenital heart surgery: The first report
of risk models from a Japanese database
Hiroaki Miyata, PhD, Arata Murakami, MD, PhD, Ai Tomotaki, RNs, MSc, Tetsuhiro Takaoka, MD,
Takeshi Konuma, MD, PhD, Goki Matsumura, MD, PhD, Syunji Sano, MD, PhD, and
Shinichi Takamoto, MD, PhD, Tokyo, JapanThe Japan Congenital Cardiovascular Surgery Database has developed risk models of congenital
heart surgery for short-term and midterm outcomes in Japan. The proposed risk scores and
categories have a high degree of discrimination for predicting mortality and represent an
improvement upon existing consensus-based methods.Editorial Commentary 2206 Risk models for pediatric and congenital cardiac surgery
Jeffrey P. Jacobs, MD, Saint Petersburg, Fla2208 Technical performance score is associated with outcomes after the Norwood
procedure
Meena Nathan, MD, Lynn A. Sleeper, ScD, Richard G. Ohye, MD, Peter C. Frommelt, MD,
Christopher A. Caldarone, MD, James S. Tweddell, MD, Minmin Lu, MS,
Gail D. Pearson, MD, ScD, J. William Gaynor, MD, Christian Pizarro, MD,
Ismee A. Williams, MD, MS, Steven D. Colan, MD, Carolyn Dunbar-Masterson, BSN, RN,
Peter J. Gruber, MD, Kevin Hill, MD, Jennifer Hirsch-Romano, MD, Jeffrey P. Jacobs, MD,
Jonathan R. Kaltman, MD, S. Ram Kumar, MD, PhD, David Morales, MD, Scott M. Bradley, MD,
Kirk Kanter, MD, and Jane W. Newburger, MD, MPH, for the Pediatric Heart Network
Investigators, Boston, Cambridge, and Watertown, Mass; Ann Arbor, Mich; Milwaukee, Wis;
Toronto, Ontario, Canada; Bethesda, Md; Philadelphia, Pa; Wilmington, Del; New York, NY; Iowa
City, Iowa; Chapel Hill, NC; St Petersburg, Fla; Los Angeles, Calif; Cincinnati, Ohio; Charleston,
SC; and Atlanta, GaTPSsmeasure the technical adequacy of repair in congenital cardiac operations. Using data from the
SVR trial, we demonstrated that the TPS could predict both early and late outcomes after the
Norwood procedure, with a class 3 (inadequate, major residual defect) TPS having poorer outcomes.)
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The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 5 29ATara Karamlou, MD, San Francisco, CalifU2216 Preliminary experience with porcine intestinal submucosa (CorMatrix) for
valve reconstruction in congenital heart disease: Histologic evaluation of
explanted valvesEDAbbas Haider Zaidi, MD, Meena Nathan, MD, Sitaram Emani, MD, Christopher Baird, MD,
Pedro J. del Nido, MD, Kimberlee Gauvreau, ScD, Marian Harris, MD, PhD,
Stephen P. Sanders, MD, and Robert F. Padera, MD, PhD, Boston, MassCD
ACorMatrix, explanted after valvuloplasty for congenital heart defects, was associated with an
intense, mixed inflammatory response lasting #9 months but underwent minimal remodeling or
tissue ingrowth. In contrast, autologous pericardium was associated with little or no inflammatory
reaction and more tissue ingrowth and remodeling.Editorial Commentary 2225 Responsible innovation
Winfield J. Wells, MD, Los Angeles, Calif2C227 Targeted imaging of matrix metalloproteinase activity in the evaluation of
remodeling tissue-engineered vascular grafts implanted in a growing lamb
modelH
DMitchel R. Stacy, PhD, Yuji Naito, MD, PhD, Mark W. Maxfield, MD, Hirotsugu Kurobe, MD, PhD,
Shuhei Tara, MD, PhD, Chung Chan, PhD, Kevin A. Rocco, MS, Toshiharu Shinoka, MD, PhD,
Albert J. Sinusas, MD, and Christopher K. Breuer, MD, New Haven, Conn, San Francisco, Calif,
and Columbus, OhioG
TSWe have demonstrated the feasibility of hybrid SPECT/CT imaging of matrix metalloproteinase
activity within TEVGs implanted in juvenile lambs. We also quantified the in vivo growth and
remodeling. Molecular imaging can improve clinical application of tissue engineering by
permitting serial assessment of vascular graft remodeling.Editorial Commentary 2S234 Understanding and not only observing: The key to success in tissue
engineering?/BDavid Kalfa, MD, PhD, New York, NY T2235 Pulmonary artery resuscitation for isolated ductal origin of a pulmonary
arteryECarlos M. Mery, MD, MPH, Kimberly M. Molina, MD, Rajesh Krishnamurthy, MD,
Charles D. Fraser, Jr, MD, and Henri Justino, MD, Houston, Tex, and Salt Lake City, UtahPM
Ductal origin of a PA is often misdiagnosed as congenital agenesis of the PA. A strategy of staged
resuscitation and centralization of the affected PAwith adjunct interventional procedures leads to
improvement in symptoms, PA growth, increased lung volume, and improved lung perfusion.)
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diagnostic and therapeutic strategies(continued on page 31A
d Cardiovascular Surgery c November 2014Sarosh P. Batlivala, MD, Doff B. McElhinney, MD, Frank A. Pigula, MD, and
Audrey C. Marshall, MD, Boston, Mass, and Jackson, MissIPADO is a rare disease with diverse presentations. Our single-center experience suggests that early
diagnosis and treatment are important for long-term outcome. Although initial intervention
depends on individual factors, we believe the ultimate goal should be early unifocalization.2253 Incidence and outcomes of right-sided endocarditis in patients with
congenital heart disease after surgical or transcatheter pulmonary valve
implantation
Sophie Malekzadeh-Milani, MD, Magalie Ladouceur, MD, Laurence Iserin, MD,
Damien Bonnet, MD, PhD, and Younes Boudjemline, MD, PhD, Paris, FranceWe compared the incidence and outcomes of right-sided endocarditis in patients with surgical and
percutaneous pulmonary valves. During the study period, there was a higher person-time incidence
of endocarditis in patients with percutaneous pulmonary valves than with surgical pulmonary
valves. However, the probability of survival was similar.Editorial Commentary 2259 Endocarditis and the transcatheter pulmonary valve
Richard A. Jonas, MD, Washington, DCGeneral Thoracic
Surgery (GTS)
2261 Readmission after lung cancer resection is associated with a 6-fold increase in
90-day postoperative mortality
Yinin Hu, MD, Timothy L. McMurry, PhD, James M. Isbell, MD, MSCI, George J. Stukenborg, PhD,
and Benjamin D. Kozower, MD, MPH, Charlottesville, VaAccording to the SEER-Medicare database, there is a 12.8% risk of readmission within 30 days after
lung cancer resection. More than one-quarter of early readmissions occur at hospitals not performing
the original operation. Patients who are readmitted have a 6-fold increase in subsequent mortality
within 90 days of surgery.Editorial Commentary 2267 The crisis of readmissions: Symptom or disease?
Varun Puri, MD, MSCI, St Louis, Mo2269 Ninety-day mortality after resection for lung cancer is nearly double 30-day
mortality
Christopher M. Pezzi, MD, Katherine Mallin, PhD, Andres Samayoa Mendez, MD,
Emmelle Greer Gay, PhD, and Joe B. Putnam, Jr, MD, Abington, Pa, Chicago, Ill, and Nashville,
TennNinety-day mortality after major lung resection for cancer is nearly double the traditional 30-day
mortality in this study, which examines 114,905 patients from more than 1200 Commission on
Cancer-accredited hospitals reported to the National Cancer Data Base from 2007 to 2011. The
impact of annual hospital volume remains significant at 90 days.)
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The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 5 31AMoishe Liberman, MD, PhD, Montreal, Quebec, CanadaU2280 The biomarker TP53 divides patients with neoadjuvantly treated esophageal
cancer into 2 subgroups with markedly different outcomes. A p53 Research
Group studyEDDaniela Kandioler, MD, MBA, Sebastian F. Schoppmann, MD, Ronald Zwrtek, MD,
Sonja Kappel, PhD, Brigitte Wolf, PhD, Martina Mittlb€ock, PhD, Irene K€uhrer, MD,
Michael Hejna, MD, Ursula Pluschnig, MD, Ahmed Ba-Ssalamah, MD, Fritz Wrba, MD, and
Johannes Zacherl, MD, Vienna and Sankt Poelten, AustriaA
CDThe biomarker TP53 divides esophageal cancer patients into 2 categories with markedly
differential outcomes: patients with a normal TP53 marker status may experience notable benefits
from neoadjuvant chemotherapy with cisplatin/fluorouracil, whereas those with a mutant TP53
marker status appear to be at risk for lack of response.Editorial Commentary 2286 Predicting response to neoadjuvant therapy in esophageal cancer with p53
genotyping: A fortune-teller’s crystal ball or a viable prognostic tool?H
DKatie S. Nason, MD, MPH, Pittsburgh, PaC2288 Systemic chemotherapy in combination with pericardial window has better
outcomes in malignant pericardial effusions
Sezai C¸elik, MD, Chiara Lestuzzi, MD, Eugenio Cervesato, PhD, Didier Dequanter, MD,
Patrizia Piotti, MD, Marzia De Biasio, MD, and Massimo Imazio, MD, Istanbul, Turkey; Aviano,
Pordenone, Milan, Udine, and Turin, Italy; and Montigny le Tielleuil, BelgiumTS
GOur study results indicate that systemic chemotherapy plus pericardial window formation is a more
effective treatment option compared with systemic chemotherapy alone and systemic
chemotherapy plus drainage in patients with confirmed malignant effusions.Editorial Commentary 2294 Percutaneous versus surgical drainage of malignant pericardial effusion: Still
no tiebreaker
Robbin G. Cohen, MD, MMM, Los Angeles, CalifB
SEvolving Technology/
Basic Science (ET/BS)
2296 Diabetic hearts have lower basal urocortin levels that fail to increase after
cardioplegic arrest: Association with increased apoptosis and postsurgical
cardiac dysfunctionET
/MCarol Chen-Scarabelli, MSc, PhD, FAHA, Richard Knight, MD, PhD, Anastasis Stephanou, PhD,
Gabriele Scarabelli, MD, Francesco Onorati, MD, PhD, Maddalena Tessari, MSc, PhD,
Alessio Rungatscher, MD, Jagat Narula, MD, PhD, FAHA, MACC, Louis Saravolatz, MD, MACP,
Alessandro Mazzucco, MD, Giuseppe Faggian, MD, and Tiziano M. Scarabelli, MD, PhD, FAHA,
Ann Arbor and Detroit, Mich; London, United Kingdom; Verona, Italy; and New York, NY PThe molecular mechanisms underlying the worse outcome of DMPs after OPCS have been poorly
defined. The DMP myocytes did not increase expression of cardioprotective Ucn and PKC3,
although expression and translocation of PKCd increased after cardioplegia, resulting in increased
apoptosis. These mechanisms might increase the postcardiac surgery morbidity of DMPs.)
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TXEditorial Commentary 232A The Journal of Thoracic an309 Myocardial protection isn’t dead yet(continued on page 33A
d Cardiovascular Surgery c November 2014Donald D. Glower, MD, Durham, NC2310 Metabolic characteristics of human hearts preserved for 12 hours by static
storage, antegrade perfusion, or retrograde coronary sinus perfusion
Michael L. Cobert, PhD, Matthew E. Merritt, PhD, LaShondra M. West, MS, Colby Ayers, MS,
Michael E. Jessen, MD, and Matthias Peltz, MD, Dallas, TexWe studiedmyocardial metabolism in human hearts rejected for transplantation that were preserved
by 2 machine perfusion preservation techniques or hypothermic static storage. Hearts perfused by
either antegrade or retrograde machine perfusion maintained indices of ongoing oxidative
metabolism and higher ATP levels compared with static storage hearts after 12 hours. Machine
perfusion seems effective for long-term preservation of donor hearts.2316 Sustained release of milrinone delivered via microparticles in a rodentmodel of
myocardial infarction
Hamood Al Kindi, MD, Arghya Paul, PhD, Zhipeng You, PhD, Oleg Nepotchatykh, PhD,
Adel Schwertani, PhD, Satya Prakash, PhD, and Dominique Shum-Tim, MD, Montreal, Quebec,
Canada; and Lawrence, KanDrug delivery using MNPs is an evolving technology that could enhance drug bioavailability and
decrease its toxicity. We describe microencapsulation of milrinone with biodegradable
microparticles and evaluate their performance using in vitro and in vivo studies. This could
represent a new drug delivery strategy for the treatment of end-stage heart failure.2325 Development of a prostacyclin-agonist–eluting aortic stent graft enhancing
biological attachment to the aortic wall
Yoshiki Watanabe, MD, Shigeru Miyagawa, MD, PhD, Satsuki Fukushima, MD, PhD,
Takashi Daimon, PhD, Yukitoshi Shirakawa, MD, PhD, Toru Kuratani, MD, PhD, and
Yoshiki Sawa, MD, PhD, Osaka and Hyogo, JapanA prostacyclin-agonist-eluting stent graft, which releases the drug into adjacent tissues over 3
months, enhanced tissue regeneration between the graft and the aortic wall in canine models,
suggesting that this device may prevent the stent graft–related complications associated with
inadequate histologic attachment to the aortic wall.2335 Lung injury after simulated cardiopulmonary bypass in an isolated perfused
rat lung preparation: Role of mitogen-activated protein kinase/Akt signaling
and the effects of theophylline
Thomais Markou, PhD, and David J. Chambers, PhD, London, United KingdomLung deflation and reinflation, such as occurs during CPB, induces lung injury and stimulates
differential activation of pulmonary p38-MAPK, ERK1/2, and Akt. Theophylline protected lungs
against CPB-induced injury but only at supratherapeutic doses. The effect was associated with
inhibition of Akt activation.)
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technetium-99m–labeled macroaggregate of albumin single photon
emission computed tomography/computed tomography with attenuation
correction(continued on page 34A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 5 33AEDLauren K. Toney, MS, MD, Michelle Wanner, BS, Robert S. Miyaoka, PhD, Adam M. Alessio, PhD,
Douglas E. Wood, MD, and Hubert Vesselle, PhD, MD, Seattle, WashSPECT/CT imagingwith attenuation correction using Tc-99mMAA for assessing lung perfusion in
preoperative lung surgery patients provides improved quantitation of lobar perfusion compared
with existing planar and SPECT methods and is expected to have a significant impact on the
functional resectability of patients with lung cancer and underlying lung disease.D2353 Establishment and comparison of two reliable hyperkinetic pulmonary
hypertension models in rabbitsA
CChuanzhen Liu, MD, Zhibo Yan, MD, PhD, Changcun Fang, MD, PhD, Guangqing Cao, MD, PhD,
BiaoWang, MD, PhD, Sijie Li, MD, and ShumingWu, MD, PhD, Jinan, People’s Republic of ChinaCH
DA reliable, convenient, and economic hyperkinetic PAH model was successfully established using
common carotid artery and jugular vein anastomosis. According to the pathologic changes and the
Heath-Edwards classification system, a reversible and an irreversible PAHmodel was established at
3 and 6 months postoperatively, respectively.2360 Venovenous perfusion-induced systemic hyperthermia: Five-day sheep
survival studies
Cherry Ballard-Croft, PhD, Dongfang Wang, MD, PhD, Kyle Rosenstein, BSE, Jingkun Wang,
Robert Pollock, BA, J. Ann Morris, BS, and Joseph B. Zwischenberger, MD, Lexington, KyTS
GThe safety and accuracy of our vv-PISH system were tested in 5-day sheep survival studies. The vv-
PISH system included a double-lumen cannula, a centrifugal pump, a heat exchanger, and a heater/
cooler. Our vv-PISH system safely delivered the therapeutic dose with no significant hyperthermia-
related complications.2367 Nature of the underlying heart disease affects survival in pediatric patients
undergoing extracorporeal cardiopulmonary resuscitationB
SET
/Joseph Philip, MD, Cole Burgman, CCP, Aarti Bavare, MD, MPH, Ayse Akcan-Arikan, MD,
Jack F. Price, MD, Iki Adachi, MD, and Lara S. Shekerdemian, MD, MHA, Gainsville, Fla, and
Houston, TexPMWe have described the use of ECMO in acute resuscitation after cardiac arrest in pediatric patients
with heart disease in a retrospective medical record review. A total of 62 episodes of ECPR
occurred in 59 patients, with 27 (46%) surviving to hospital discharge and 25 (43%) alive at the
most recent follow-up visit. No patient with restrictive cardiomyopathy survived, although 1 patient
in late cardiac graft failure (13%) survived. Our results have shown that ECPR survival is associated
with the underlying disease.)
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234A The Journal of Thoracic an373 Myocardial damage influences short- and mid-term survival after valve
surgery: A prospective multicenter study(continued on page 35A
d Cardiovascular Surgery c November 2014Domenico Paparella, MD, Pietro Guida, PhD, Sergio Caparrotti, MD, Vitantonio Fanelli, MD,
Gianluca Martinelli, MD, Valerio Mazzei, MD, Salvatore Zaccaria, MD, Lucia Bisceglia, MD, and
Giuseppe Scrascia, MD, Bari, Taranto, and Lecce, ItalyMyocardial damage after AVS and MVS, measured by postoperative cTnI peak values, was
associated with postoperative morbidity and mortality, with significant improvement in the risk
reclassification of patients. It should be added to preoperative and intraoperative risk factors to better
identify high-risk patients needing tailored management.Editorial Commentary 2380 Heart and soul
Alden H. Harken, MD, FACS, Oakland, Calif2381 Implementation of bundled interventions greatly decreases deep sternal wound
infection following cardiovascular surgery
Ken Miyahara, MD, Akio Matsuura, MD, Haruki Takemura, MD, Shinichi Mizutani, MD,
Shunei Saito, MD, and Masashi Toyama, MD, Ichinomiya, Aichi, JapanWe introduced and implemented an infection preventive bundle to reduce surgical site infection
after cardiovascular surgery and evaluated its effectiveness. Compared with the preintervention
period, the deep sternal wound infection rate during the postintervention period was significantly
(93%) reduced from 1.9% to 0.14% (P 5 .001).Editorial Commentary 2388 An ounce of prevention is worth a pound of cure
Kevin L. Greason, MD, Rochester, Minn2390 Scoring system to guide decisionmaking for the use of gentamicin-impregnated
collagen sponge to prevent deep sternal wound infection
Umberto Benedetto, MD, PhD, and Shahzad G. Raja, MRCS, FRCS(C-Th), on behalf of the
Harefield Cardiac Outcomes Research Group, London, United KingdomThe effectiveness of the routine retrosternal placement of a gentamicin-impregnated collagen
sponge implant before sternotomy closure is currently a matter of some controversy. We developed
a scoring system to guide decision making for the use of gentamicin-impregnated collagen sponges
to prevent deep sternal wound infection.2397 Negative pressure wound treatment improves Acute Physiology and Chronic
Health Evaluation II score in mediastinitis allowing a successful elective
pectoralis muscle flap closure: Six-year experience of a single protocol
Andrea Salica, MD, Luca Weltert, MD, Raffaele Scaffa, MD, Lorenzo Guerrieri Wolf, MD,
Saverio Nardella, MD, Alessandro Bellisario, MD, and Ruggero De Paulis, MD, Rome, ItalyNegative pressure wound treatment improves the wound environment and restores sternal stability
with low surgical invasiveness. Within the first 48 hours, the treatment significantly improves the
APACHE II score. This approach promotes a complete clinical recovery and wound sterilization,
allowing the patient to withstand chest wall closure in good general condition.)
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and economic implications from national data(continued on page 36A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 5 35AED
UAndrew Flagg, BS, Colleen G. Koch, MD, MS, MBA, Nicholas Schiltz, PhD,
Aiswarya Chandran Pillai, MD, MS, Steven M. Gordon, MD, G€osta B. Pettersson, MD, PhD, and
Edward G. Soltesz, MD, MPH, Cleveland, OhioCDIs in cardiac surgical patients are associated with considerable increased morbidity and resource
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